Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 16.75B | $ 14.24B | $ 12.68B | $ 11.89B | $ 9.91B |
| Gross Profit | $ 11.49B | $ 9.89B | $ 8.68B | $ 8.13B | $ 6.40B |
| Operating Income | $ 2.60B | $ 2.34B | $ 1.65B | $ 2.04B | $ 1.04B |
| EBITDA | $ 2.60B | $ 3.45B | $ 2.74B | $ 2.52B | $ 1.51B |
| Net Income | $ 1.85B | $ 1.59B | $ 698.00M | $ 1.04B | $ -140.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 414.00M | $ 865.00M | $ 928.00M | $ 1.93B | $ 1.73B |
| Total Assets | $ 39.40B | $ 35.14B | $ 32.47B | $ 32.23B | $ 30.78B |
| Total Debt | $ 10.75B | $ 9.49B | $ 9.28B | $ 9.45B | $ 9.54B |
| Net Debt | $ 10.33B | $ 8.63B | $ 8.35B | $ 7.53B | $ 7.80B |
| Total Liabilities | $ 17.39B | $ 15.61B | $ 14.90B | $ 15.61B | $ 15.45B |
| Stockholders' Equity | $ 21.77B | $ 19.28B | $ 17.57B | $ 16.62B | $ 15.33B |
| Cash Flow | |||||
| Free Cash Flow | $ 2.65B | $ 1.70B | $ 914.00M | $ 1.32B | $ 1.13B |
| Operating Cash Flow | $ 3.44B | $ 2.50B | $ 1.53B | $ 1.87B | $ 1.51B |
| Investing Cash Flow | $ -5.69B | $ -2.57B | $ -2.01B | $ -1.60B | $ -411.00M |
| Financing Cash Flow | $ 1.81B | $ 5.00M | $ -548.00M | $ -95.00M | $ 293.00M |